DOCSLIB.ORG

Mechanisms of Regulation and Diversification of Deubiquitylating Enzyme Function Pawel Leznicki* and Yogesh Kulathu*

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mechanisms of Regulation and Diversification of Deubiquitylating Enzyme Function Pawel Leznicki* and Yogesh Kulathu* © 2017. Published by The Company of Biologists Ltd | Journal of Cell Science (2017) 130, 1997-2006 doi:10.1242/jcs.201855 COMMENTARY Mechanisms of regulation and diversification of deubiquitylating enzyme function Pawel Leznicki* and Yogesh Kulathu* ABSTRACT been linked to the pathogenesis of a number of human diseases, Deubiquitylating (or deubiquitinating) enzymes (DUBs) are such as cancer, and neurodegenerative, inflammatory and proteases that reverse protein ubiquitylation and therefore metabolic disorders (Heideker and Wertz, 2015). modulate the outcome of this post-translational modification. Approximately 100 DUBs are encoded in the human genome DUBs regulate a variety of intracellular processes, including (Nijman et al., 2005b). Depending on the organization of the protein turnover, signalling pathways and the DNA damage catalytic domain, DUBs can be classified into distinct families response. They have also been linked to a number of human (Table 1), the vast majority of which are cysteine proteases. These diseases, such as cancer, and inflammatory and neurodegenerative include ubiquitin-specific proteases (USPs), ubiquitin C-terminal – disorders. Although we are beginning to better appreciate the role of hydrolases (UCHs), ovarian tumour proteases (OTUs), Machado DUBs in basic cell biology and their importance for human health, Joseph disease proteases (MJDs) and the recently discovered MIU- there are still many unknowns. Central among these is the containing novel DUB family (MINDY) proteases (Abdul Rehman conundrum of how the small number of ∼100 DUBs encoded in et al., 2016). Additionally, there is also a metalloproteinase family the human genome is capable of regulating the thousands of of DUBs, the JAB1/MPN/Mov34 (JAMM) domain proteases ubiquitin modification sites detected in human cells. This (Nijman et al., 2005b). Strikingly, although DUBs have been Commentary addresses the biological mechanisms employed to implicated in many cellular processes, in most cases their precise modulate and expand the functions of DUBs, and sets directions for function is still either poorly characterized or completely unknown. future research aimed at elucidating the details of these fascinating Importantly, there are at least 600 E3 ubiquitin ligases, and at ∼ processes. steady-state conditions, 20,000 ubiquitylation sites on thousands This article is part of a Minifocus on Ubiquitin Regulation and of intracellular proteins can be detected (Clague et al., 2015; Kim Function. For further reading, please see related articles: et al., 2011; Udeshi et al., 2013). How a relatively small number of ‘Exploitation of the host cell ubiquitin machinery by microbial DUBs manages to regulate such a vast number of modifications is effector proteins’ by Yi-Han Lin and Matthias P. Machner (J. Cell one of the key unsolved questions in the field. In this Commentary, Sci. 130, 1985–1996). ‘Cell scientist to watch – Mads Gyrd-Hansen’ we will discuss the different layers of regulation of DUB activity that (J. Cell Sci. 130, 1981–1983). ensure that DUBs are activated, regulated and targeted to their appropriate substrates to achieve precise spatio-temporal control of KEY WORDS: Deubiquitinase, Deubiquitylase, Signal transduction, ubiquitin signals within a specific physiological pathway. We will Ubiquitylation discuss these concepts with an emphasis on how functional diversification of DUBs can be achieved. Introduction Post-translational attachment of ubiquitin, or ubiquitylation, Regulation of DUB abundance controls most intracellular processes, including protein turnover, Conceptually, the simplest mechanism for modulating the activity, intracellular signalling, endocytosis and the DNA damage and hence biological function, of a given protein is by regulating response (Clague and Urbe, 2017; Heideker and Wertz, 2015; its intracellular concentration. This also applies to DUBs, whose Kee and Huang, 2015). Ubiquitin is most often conjugated to abundance can be controlled both via transcription or translation lysine residues of target proteins in a reaction catalysed by an and via degradation. For example, levels of several DUBs are enzymatic cascade that involves the E1 activating, E2 conjugating regulated in a cell cycle-dependent manner and are directly related and E3 ligating enzymes. Importantly, ubiquitin can also be ligated to their function. USP37 is one such DUB, and its transcription to any of the seven internal lysine residues or the N-terminal is controlled by the E2F transcription factors, resulting in high methionine of another ubiquitin, forming chains whose linkage USP37 levels during the G1/S transition (Huang et al., 2011). type defines the outcome of protein ubiquitylation. Ubiquitylation This in turn allows for the stabilization of cyclin A and cell can be reversed by deubiquitylating (or deubiquitinating) enzymes cycle progression into S phase. Interestingly, USP37 is degraded in (DUBs) that cleave ubiquitin off the substrate protein or within mitosis by the anaphase-promoting complex (APC) containing ubiquitins in a polyubiquitin chain (Fig. 1). The importance of the CDH1 (also known as FZR1) (APCCDH1) (Huang et al., 2011). components of the ubiquitin conjugation and deconjugation Similarly, levels of USP33 oscillate during the cell cycle, which has systems is underscored by the fact that their deregulation has implications for USP33-mediated stabilization of CP110, a centriolar protein that controls cell cycle-dependent centrosome MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, duplication (Li et al., 2013). Transcription of A20 (also known as University of Dundee, Dow Street, Dundee DD1 5EH, UK. TNFAIP3) and cylindromatosis (CYLD), modulators of nuclear factor (NF)-κB signalling, is also tightly regulated and induced in *Authors for correspondence ([email protected]; [email protected]) response to NF-κB activation in a feedback loop to inhibit the Y.K., 0000-0002-3274-1642 pathway (Pahl, 1999; Sun, 2010). Moreover, several DUBs are Journal of Cell Science 1997 COMMENTARY Journal of Cell Science (2017) 130, 1997-2006 doi:10.1242/jcs.201855 (>600) (40) E3 ATP E2 Substrate Ub (2) E1 E1 Ub E2Ub E2 Ub E3 AMP+PPi Activation Conjugation E1 E2 Substrate Ligation Substrate Ub Ub Substrate Substrate Substrate Ub Ub Ub Ub Ub Ub Ub Ub Deubiquitylation Ub Ub Ub Ub Ub Ub Ub Ub Ub Ub DUB DUB Multi- Monoubiquitylation monoubiquitylation Polyubiquitylation (~100) Ubiquitylation sites: ~ 20,000 Fig. 1. Overview of protein ubiquitylation. Ubiquitin (Ub) is activated and transferred to a substrate protein in a cascade reaction catalysed by E1 activating, E2 conjugating and E3 ligating enzymes. This can lead to the formation of distinct types of modifications, all of which can potentially be reversed by deubiquitylating enzymes (DUBs). Numbers in brackets indicate the number of members for each family of enzymes. ubiquitylated and some, such as USP4 (Zhang et al., 2012), can these DUBs not only enhances their catalytic activity but also auto-deubiquitylate and hence counteract their own ubiquitin- places them within the context of the proteasome, where they can mediated degradation. Therefore, transcriptional and post- influence different stages of protein degradation. Hence, USP14 translational mechanisms regulate the abundance of DUBs and and UCH37 can potentially modulate the ubiquitylation status of thus their functions. This regulation can also be cell type-specific, proteins prior to their commitment for degradation, whereas Rpn11 enabling fine tuning of ubiquitin signalling. acts at later stages (Worden et al., 2014). Interestingly, UCH37 is also part of another complex, the chromatin-remodelling INO80 Interacting partners of DUBs complex, in which its activity is inhibited (Yao et al., 2008). Elegant Interacting partners are key regulators of the biological functions of structural studies have revealed that equivalent DEUBiquitylase DUBs and can affect their catalytic activity and facilitate substrate ADaptor (DEUBAD) domains present in both Rpn13 (also known recognition. Indeed, in some cases, a DUB is essentially inactive as ADRM1 in mammals) and INO80G (also known as NFRKB) unless it is incorporated into a protein complex. This is particularly induce distinct structural rearrangements in UCH37 that result in its evident in the case of large macromolecular assemblies that contain activation at the proteasome and inhibition at the INO80 complex, DUBs as functional subunits. For example, all three proteasome- respectively (Sahtoe et al., 2015; VanderLinden et al., 2015). associated DUBs, the metalloproteinase Rpn11 (also known as Akin to the recruitment of UCH37 into two distinct complexes, PSMD14) and the two cysteine proteases USP14 and UCH37 (also the proteasome and the INO80 complex, BRCC36 (a member of the known as UCHL5), are significantly activated upon incorporation JAMM DUB family) is incorporated into two alternative into the 19S regulatory particle (Borodovsky et al., 2001; Qiu et al., complexes, the nuclear Abraxas complex (ARISC) and cytosolic 2006; Worden et al., 2014; Yao et al., 2006). Recruitment of BRCC36 isopeptidase complex (BRISC). Both the ARISC and BRISC complexes share the core subunits, BRCC45 and MERIT40 Table 1. DUBs are divided into several families (also known as BRE and BABAM1 , respectively), but in addition Family Members Active they also contain complex-specific components, namely, Abro1 (also known as KIAA0157 and FAM175B) for the BRISC complex USP 57 51 OTU
Load more

Recommended publications
  • Deciphering the Functions of Ets2, Pten and P53 in Stromal Fibroblasts in Multiple
    Deciphering the Functions of Ets2, Pten and p53 in Stromal Fibroblasts in Multiple Breast Cancer Models DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Julie Wallace Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2013 Dissertation Committee: Michael C. Ostrowski, PhD, Advisor Gustavo Leone, PhD Denis Guttridge, PhD Dawn Chandler, PhD Copyright by Julie Wallace 2013 Abstract Breast cancer is the second most common cancer in American women, and is also the second leading cause of cancer death in women. It is estimated that nearly a quarter of a million new cases of invasive breast cancer will be diagnosed in women in the United States this year, and approximately 40,000 of these women will die from breast cancer. Although death rates have been on the decline for the past decade, there is still much we need to learn about this disease to improve prevention, detection and treatment strategies. The majority of early studies have focused on the malignant tumor cells themselves, and much has been learned concerning mutations, amplifications and other genetic and epigenetic alterations of these cells. However more recent work has acknowledged the strong influence of tumor stroma on the initiation, progression and recurrence of cancer. Under normal conditions this stroma has been shown to have protective effects against tumorigenesis, however the transformation of tumor cells manipulates this surrounding environment to actually promote malignancy. Fibroblasts in particular make up a significant portion of this stroma, and have been shown to impact various aspects of tumor cell biology.
    [Show full text]
  • CYLD Is a Deubiquitinating Enzyme That Negatively Regulates NF-Kb
    letters to nature 13. Schwartz, S. et al. Human–mouse alignments with BLASTZ. Genome Res 13, 103–107 (2003). necrosis factor receptors (TNFRs). Loss of the deubiquitinating 14. Schwartz, S. et al. MultiPipMaker and supporting tools: alignments and analysis of multiple genomic activity of CYLD correlates with tumorigenesis. CYLD inhibits DNA sequences. Nucleic Acids Res. 31, 3518–3524 (2003). 15.Murphy,W.J.et al. Resolution of the early placental mammal radiation using Bayesian phylogenetics. activation of NF-kB by the TNFR family members CD40, XEDAR Science 294, 2348–2351 (2001). and EDAR in a manner that depends on the deubiquitinating 16. Poux, C., Van Rheede, T., Madsen, O. & de Jong, W. W. Sequence gaps join mice and men: activity of CYLD. Downregulation of CYLD by RNA-mediated phylogenetic evidence from deletions in two proteins. Mol. Biol. Evol. 19, 2035–2037 (2002). 17. Huelsenbeck, J. P., Larget, B. & Swofford, D. A compound Poisson process for relaxing the molecular interference augments both basal and CD40-mediated activation clock. Genetics 154, 1879–1892 (2000). of NF-kB. The inhibition of NF-kBactivationbyCYLDis 18. Cooper, G. M. et al. Quantitative estimates of sequence divergence for comparative analyses of mediated, at least in part, by the deubiquitination and inacti- mammalian genomes. Genome Res. 13, 813–820 (2003). vation of TNFR-associated factor 2 (TRAF2) and, to a lesser 19. Siepel, A. & Haussler, D. Proc. 7th Annual Int. Conf. Research in Computational Molecular Biology (ACM, New York, 2003). extent, TRAF6. These results indicate that CYLD is a negative 20. Hardison, R. C. et al. Covariation in frequencies of substitution, deletion, transposition, and regulator of the cytokine-mediated activation of NF-kB that is recombination during eutherian evolution.
    [Show full text]
  • A Drosophila Ortholog of the Human Cylindromatosis Tumor Suppressor
    RESEARCH ARTICLE 2605 Development 134, 2605-2614 (2007) doi:10.1242/dev.02859 A Drosophila ortholog of the human cylindromatosis tumor suppressor gene regulates triglyceride content and antibacterial defense Theodore Tsichritzis1, Peer C. Gaentzsch3, Stylianos Kosmidis2, Anthony E. Brown3, Efthimios M. Skoulakis2, Petros Ligoxygakis3,* and George Mosialos1,4,* The cylindromatosis (CYLD) gene is mutated in human tumors of skin appendages. It encodes a deubiquitylating enzyme (CYLD) that is a negative regulator of the NF-␬B and JNK signaling pathways, in vitro. However, the tissue-specific function and regulation of CYLD in vivo are poorly understood. We established a genetically tractable animal model to initiate a systematic investigation of these issues by characterizing an ortholog of CYLD in Drosophila. Drosophila CYLD is broadly expressed during development and, in adult animals, is localized in the fat body, ovaries, testes, digestive tract and specific areas of the nervous system. We demonstrate that the protein product of Drosophila CYLD (CYLD), like its mammalian counterpart, is a deubiquitylating enzyme. Impairment of CYLD expression is associated with altered fat body morphology in adult flies, increased triglyceride levels and increased survival under starvation conditions. Furthermore, flies with compromised CYLD expression exhibited reduced resistance to bacterial infections. All mutant phenotypes described were reversible upon conditional expression of CYLD transgenes. Our results implicate CYLD in a broad range of functions associated with fat homeostasis and host defence in Drosophila. KEY WORDS: Cylindromatosis, Drosophila, Fat body, Host defense, NF-kappaB INTRODUCTION disease and it is required for the proper development of T Familial cylindromatosis is an autosomal-dominant predisposition lymphocytes in mice (Costello et al., 2005; Reiley et al., 2006).
    [Show full text]
  • The Basal Bodies of Chlamydomonas Reinhardtii Susan K
    Dutcher and O’Toole Cilia (2016) 5:18 DOI 10.1186/s13630-016-0039-z Cilia REVIEW Open Access The basal bodies of Chlamydomonas reinhardtii Susan K. Dutcher1* and Eileen T. O’Toole2 Abstract The unicellular green alga, Chlamydomonas reinhardtii, is a biflagellated cell that can swim or glide. C. reinhardtii cells are amenable to genetic, biochemical, proteomic, and microscopic analysis of its basal bodies. The basal bodies contain triplet microtubules and a well-ordered transition zone. Both the mother and daughter basal bodies assemble flagella. Many of the proteins found in other basal body-containing organisms are present in the Chlamydomonas genome, and mutants in these genes affect the assembly of basal bodies. Electron microscopic analysis shows that basal body duplication is site-specific and this may be important for the proper duplication and spatial organization of these organelles. Chlamydomonas is an excellent model for the study of basal bodies as well as the transition zone. Keywords: Site-specific basal body duplication, Cartwheel, Transition zone, Centrin fibers Phylogeny and conservation of proteins Centrin, SPD2/CEP192, Asterless/CEP152; CEP70, The green lineage or Viridiplantae consists of the green delta-tubulin, and epsilon-tubulin. Chlamydomonas has algae, which include Chlamydomonas, the angiosperms homologs of all of these based on sequence conservation (the land plants), and the gymnosperms (conifers, cycads, except PLK4, CEP152, and CEP192. Several lines of evi- ginkgos). They are grouped together because they have dence suggests that CEP152, CEP192, and PLK4 interact chlorophyll a and b and lack phycobiliproteins. The green [20, 52] and their concomitant absence in several organ- algae together with the cycads and ginkgos have basal isms suggests that other mechanisms exist that allow for bodies and cilia, while the angiosperms and conifers have control of duplication [4].
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Deubiquitinases in Cancer: New Functions and Therapeutic Options
    Oncogene (2012) 31, 2373–2388 & 2012 Macmillan Publishers Limited All rights reserved 0950-9232/12 www.nature.com/onc REVIEW Deubiquitinases in cancer: new functions and therapeutic options JM Fraile1, V Quesada1, D Rodrı´guez, JMP Freije and C Lo´pez-Otı´n Departamento de Bioquı´mica y Biologı´a Molecular, Facultad de Medicina, Instituto Universitario de Oncologı´a, Universidad de Oviedo, Oviedo, Spain Deubiquitinases (DUBs) have fundamental roles in the Hunter, 2010). Consistent with the functional relevance ubiquitin system through their ability to specifically of proteases in these processes, alterations in their deconjugate ubiquitin from targeted proteins. The human structure or in the mechanisms controlling their genome encodes at least 98 DUBs, which can be grouped spatiotemporal expression patterns and activities cause into 6 families, reflecting the need for specificity in diverse pathologies such as arthritis, neurodegenerative their function. The activity of these enzymes affects the alterations, cardiovascular diseases and cancer. Accord- turnover rate, activation, recycling and localization ingly, many proteases are an important focus of of multiple proteins, which in turn is essential for attention for the pharmaceutical industry either as drug cell homeostasis, protein stability and a wide range of targets or as diagnostic and prognostic biomarkers signaling pathways. Consistent with this, altered DUB (Turk, 2006; Drag and Salvesen, 2010). function has been related to several diseases, including The recent availability of the genome sequence cancer. Thus, multiple DUBs have been classified as of different organisms has facilitated the identification oncogenes or tumor suppressors because of their regula- of their entire protease repertoire, which has been tory functions on the activity of other proteins involved in defined as degradome (Lopez-Otin and Overall, 2002).
    [Show full text]
  • To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants
    Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By Shama K Khokhar M.Sc., Bilaspur University, 2004 B.Sc., Bhopal University, 2002 2007 1 COPYRIGHT SHAMA K KHOKHAR 2007 2 WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES Date of Defense: 12-03-07 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY SHAMA KHAN KHOKHAR ENTITLED Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science Madhavi P. Kadakia, Ph.D. Thesis Director Daniel Organisciak , Ph.D. Department Chair Committee on Final Examination Madhavi P. Kadakia, Ph.D. Steven J. Berberich, Ph.D. Michael Leffak, Ph.D. Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies 3 Abstract Khokhar, Shama K. M.S., Department of Biochemistry and Molecular Biology, Wright State University, 2007 Differential effect of TAp63γ mutants on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. p63, a member of the p53 gene family, known to play a role in development, has more recently also been implicated in cancer progression. Mice lacking p63 exhibit severe developmental defects such as limb truncations, abnormal skin, and absence of hair follicles, teeth, and mammary glands. Germline missense mutations of p63 have been shown to be responsible for several human developmental syndromes including SHFM, EEC and ADULT syndromes and are associated with anomalies in the development of organs of epithelial origin.
    [Show full text]
  • Supplemental Information Proximity Interactions Among Centrosome
    Current Biology, Volume 24 Supplemental Information Proximity Interactions among Centrosome Components Identify Regulators of Centriole Duplication Elif Nur Firat-Karalar, Navin Rauniyar, John R. Yates III, and Tim Stearns Figure S1 A Myc Streptavidin -tubulin Merge Myc Streptavidin -tubulin Merge BirA*-PLK4 BirA*-CEP63 BirA*- CEP192 BirA*- CEP152 - BirA*-CCDC67 BirA* CEP152 CPAP BirA*- B C Streptavidin PCM1 Merge Myc-BirA* -CEP63 PCM1 -tubulin Merge BirA*- CEP63 DMSO - BirA* CEP63 nocodazole BirA*- CCDC67 Figure S2 A GFP – + – + GFP-CEP152 + – + – Myc-CDK5RAP2 + + + + (225 kDa) Myc-CDK5RAP2 (216 kDa) GFP-CEP152 (27 kDa) GFP Input (5%) IP: GFP B GFP-CEP152 truncation proteins Inputs (5%) IP: GFP kDa 1-7481-10441-1290218-1654749-16541045-16541-7481-10441-1290218-1654749-16541045-1654 250- Myc-CDK5RAP2 150- 150- 100- 75- GFP-CEP152 Figure S3 A B CEP63 – – + – – + GFP CCDC14 KIAA0753 Centrosome + – – + – – GFP-CCDC14 CEP152 binding binding binding targeting – + – – + – GFP-KIAA0753 GFP-KIAA0753 (140 kDa) 1-496 N M C 150- 100- GFP-CCDC14 (115 kDa) 1-424 N M – 136-496 M C – 50- CEP63 (63 kDa) 1-135 N – 37- GFP (27 kDa) 136-424 M – kDa 425-496 C – – Inputs (2%) IP: GFP C GFP-CEP63 truncation proteins D GFP-CEP63 truncation proteins Inputs (5%) IP: GFP Inputs (5%) IP: GFP kDa kDa 1-135136-424425-4961-424136-496FL Ctl 1-135136-424425-4961-424136-496FL Ctl 1-135136-424425-4961-424136-496FL Ctl 1-135136-424425-4961-424136-496FL Ctl Myc- 150- Myc- 100- CCDC14 KIAA0753 100- 100- 75- 75- GFP- GFP- 50- CEP63 50- CEP63 37- 37- Figure S4 A siCtl
    [Show full text]
  • Untying the Knot: Protein Quality Control in Inherited Cardiomyopathies
    Pflügers Archiv - European Journal of Physiology https://doi.org/10.1007/s00424-018-2194-0 INVITED REVIEW Untying the knot: protein quality control in inherited cardiomyopathies Larissa M. Dorsch1 & Maike Schuldt1 & Dora Knežević1 & Marit Wiersma1 & Diederik W. D. Kuster1 & Jolanda van der Velden1 & Bianca J. J. M. Brundel1 Received: 30 July 2018 /Accepted: 6 August 2018 # The Author(s) 2018 Abstract Mutations in genes encoding sarcomeric proteins are the most important causes of inherited cardiomyopathies, which are a major cause of mortality and morbidity worldwide. Although genetic screening procedures for early disease detection have been improved significantly, treatment to prevent or delay mutation-induced cardiac disease onset is lacking. Recent findings indicate that loss of protein quality control (PQC) is a central factor in the disease pathology leading to derailment of cellular protein homeostasis. Loss of PQC includes impairment of heat shock proteins, the ubiquitin-proteasome system, and autophagy. This may result in accumulation of misfolded and aggregation-prone mutant proteins, loss of sarcomeric and cytoskeletal proteins, and, ultimately, loss of cardiac function. PQC derailment can be a direct effect of the mutation-induced activation, a compensa- tory mechanism due to mutation-induced cellular dysfunction or a consequence of the simultaneous occurrence of the mutation and a secondary hit. In this review, we discuss recent mechanistic findings on the role of proteostasis derailment in inherited cardiomyopathies, with special focus on sarcomeric gene mutations and possible therapeutic applications. Keywords Cardiomyopathy .Proteinqualitycontrol .Sarcomericmutation .Heatshockproteins .Ubiquitin-proteasomesystem . Autophagy Classification of cardiomyopathies occurring asymmetrically, and dilated CM (DCM), in which the presence of LV dilatation is accompanied by contractile Cardiomyopathies (CM) constitute one of the most common dysfunction [24].
    [Show full text]
  • PSMD14 Is Over-Expressed in Human Endometrial Cancer
    Over-expression of proteasome 26S subunit, non-ATPase 14 in human endometrial cancer. Shahan Mamoor, MS1 [email protected] East Islip, NY USA Gynecologic cancers including cancers of the endometrium are a clinical problem1-4. We mined published microarray data5,6 to discover genes associated with endometrial cancers by comparing transcriptomes of the normal and hyperplastic endometrium to endometrial tumors from humans. We identified proteasome 26S subunit, non-ATPase 14, encoded by PSMD14, as among the most differentially expressed genes, transcriptome-wide, in cancers of the endometrium. PSMD14 was expressed at significantly higher levels in endometrial tumor tissues as compared to the endometrium. Importantly, in human endometrial cancer, primary tumor expression of PSMD14 was correlated with overall survival in white patients with low mutational burden. PSMD14 may be a molecule of interest in understanding the etiology or progression of human endometrial cancer. Keywords: endometrial cancer, gynecologic cancers, endometrium, PSMD14, proteasome 26S subunit, non-ATPase 14, systems biology of endometrial cancer, targeted therapeutics in endometrial cancer. 1 Endometrial cancer is the most common gynecologic cancer in the developed world1. Over the last three decades, the incidence of endometrial cancer has increased 21%4 and the death rate has increased 100%3. We harnessed the power of independently published microarray datasets5,6 to determine in an unbiased fashion and at the systems-level genes most differentially expressed in endometrial tumors. We report here the differential and increased expression of the proteasome 26S subunit, non-ATPase 14 (PSMD14) in human endometrial cancer. Methods We utilized datasets GSE636785 and GSE1061916 for this global differential gene expression analysis of human endometrial cancer in conjunction with GEO2R.
    [Show full text]
  • Holdase Activity of Secreted Hsp70 Masks Amyloid-Β42 Neurotoxicity in Drosophila
    Holdase activity of secreted Hsp70 masks amyloid-β42 neurotoxicity in Drosophila Pedro Fernandez-Funeza,b,c,1, Jonatan Sanchez-Garciaa, Lorena de Menaa, Yan Zhanga, Yona Levitesb, Swati Kharea, Todd E. Goldea,b, and Diego E. Rincon-Limasa,b,c,1 aDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32611; bDepartment of Neuroscience, Center for Translational Research on Neurodegenerative Diseases, University of Florida, Gainesville, FL 32611; and cGenetics Institute, University of Florida, Gainesville, FL 32611 Edited by Nancy M. Bonini, University of Pennsylvania, Philadelphia, PA, and approved July 11, 2016 (received for review May 25, 2016) Alzheimer’s disease (AD) is the most prevalent of a large group of cell-free systems by dissociating preformed oligomers but not fi- related proteinopathies for which there is currently no cure. Here, we brils, suggesting that Hsp70 targets oligomeric intermediates (18). used Drosophila to explore a strategy to block Aβ42 neurotoxicity More recent in vitro studies show that Hsp70 and other chaperones through engineering of the Heat shock protein 70 (Hsp70), a chap- promote the aggregation of oligomers into less toxic species (19). erone that has demonstrated neuroprotective activity against several Also, Hsp70 demonstrates neuroprotection against intracellular intracellular amyloids. To target its protective activity against extra- Aβ42 in primary cultures (20), whereas down-regulation of Hsp70 cellular Aβ42, we added a signal peptide to Hsp70. This secreted form leads to increased protein aggregation in transgenic worms of Hsp70 (secHsp70) suppresses Aβ42 neurotoxicity in adult eyes, expressing intracellular Aβ42 (21). A recent study in a transgenic reduces cell death, protects the structural integrity of adult neurons, mouse model of AD overexpressing the Amyloid precursor pro- alleviates locomotor dysfunction, and extends lifespan.
    [Show full text]
  • Pathways of Cellular Proteostasis in Aging and Disease
    JCB: Review Pathways of cellular proteostasis in aging and disease Courtney L. Klaips, Gopal Gunanathan Jayaraj, and F. Ulrich Hartl Department of Cellular Biochemistry, Max Planck Institute of Biochemistry, Martinsried, Germany Ensuring cellular protein homeostasis, or proteostasis, re- control of abundance and subcellular localization, and finally, quires precise control of protein synthesis, folding, confor- disposal by degradation. A complex proteostasis network (PN) acts at each of these mational maintenance, and degradation. A complex and steps to maintain a balanced proteome linked by molecular adaptive proteostasis network coordinates these processes chaperones of different classes as central players. These factors with molecular chaperones of different classes and their ensure de novo folding in a crowded cellular environment and regulators functioning as major players. This network maintain proteins in a soluble, nonaggregated state. Moreover, in conditions that disfavor folding or solubility, certain chaper- serves to ensure that cells have the proteins they need ones act to target misfolded proteins for degradation or spatial while minimizing misfolding or aggregation events that sequestration, thus protecting the rest of the proteome from ab- are hallmarks of age-associated proteinopathies, includ- errant interactions (Balchin et al., 2016; Sontag et al., 2017). Here, we describe the major pathways of cellular pro- ing neurodegenerative disorders such as Alzheimer’s and teostasis and outline the challenges they face during aging and Parkinson’s diseases. It is now clear that the capacity of disease. We exemplify these processes using mainly the proteo- cells to maintain proteostasis undergoes a decline during stasis pathways operating in the cytosol, where most cellular aging, rendering the organism susceptible to these pa- proteins are produced.
    [Show full text]